|
Macula Complete 180 gels | BioSyntrx General Overview of Macula Complete Macula Complete is a premium broad-spectrum dietary supplement of vitamins, minerals and antioxidant phytochemicals designed to support optimal body and retinal function. When you take Macula Complete you do not need additional multiple vitamin supplements. Macula Complete is manufactured in a NSF GMP registered facility. Macula Complete includes the nutrients used the three major studies on nutrition as it relates to eye health.
- ARED study
- Lutein Antioxidant Supplement Trial (LAST)
- Phototrope Study (with the exception of Omega-3 fatty acids, which we present as a stand along product, ZoOmega-3, to ensure fatty acid stability.
These studies showed virtually no AMD disease progression in the study participants over a one year period. We also added efficacious amounts of Alpha Lipoic Acid, CoQ10, and Acetyl-L-Carnitine which have been suggested in peer-reviewed studies to support the mitochondria, as well as to support production of cellular (ATP) energy. Macula Complete is an appropriate supplement for those AMD patients who have or those who have or continue to smoke since it includes only 500 IUs of beta-carotene as a singlet oxygen quencher, not as a source of Vitamin A. The AREDS formulation includes 25,000 IUs of beta carotene; the amount has been linked to increased risk of lung cancer in those who smoke. Recent data published in The American Journal of Epidemiology suggests that smokers who consume small amounts of natural supplemental beta carotene in combination with a wide variety of supplemental antioxidants actually have an overall lower risk of developing lung and other cancers. However, please do not view the last statement as an excuse to continue smoking. Macula Complete contains all of the nutrients included in our less potent formulation, Oculair, including the B vitamins suggested to control blood levels of homocysteine, which has been suggested to increase the risk of developing AMD, plus potent levels of the vitamins, minerals, and antioxidants suggested in recent peer-reviewed scientific literature to address cataract formation, as well as vascular related inflammatory diseases of the entire body, and other diseases of the eye, such as glaucoma and diabetic retinopathy. The nutrient levels in Macula Complete do not exceed the Institute of Medicine's (IOM) safe upper limits for long-term daily consumption. Macula Complete is properly balanced with a full-spectrum of minerals, including zinc, copper and manganese, which are all three required to produce manganese super-oxide dismutase (Mn SOD), which is necessary to neutralize singlet oxygen and the super-oxide free-radicals suggested to contribute to vascular disease and degenerative diseases of the eyes, including macula degeneration. This issue is not adequately addressed in products that only include the ingredients in the ARED study formulation. Macula Complete is biochemically formulated to address hydrocarbon and xanthophyll carotenoid tissue preference, therefore it includes carefully balanced carotenoids, which facilitates the transport of 16 mg of macula pigment prefered, lutein and zeaxanthin xanthophylls to the retina. The zeaxanthin level shown on the Macula Complete supplement fact box represents the amount of supplemental zeaxanthin actually included in the formulation, not the amount though to be converted from lutein. Current label law allows manufacturers to claim zeaxanthin through conversion, which would allow Biosyntrx to claim an additional one mg of zeaxanthin. Our science team prefers to list the ingredients that are actually in the formulation. It is suggested in scientific literature that excessive amounts of the hydrocarbon carotenoid, beta-carotene, interferes with xanthophyll absorption. If taken as separate nutrients, it would be necessary to take forty-six capsules a day and to spend over $225.00 a month to equal the active ingredient nutrients included in six capsules a day of Macula Complete. The cost of Macula Complete is one quarter that amount. Age related macular degeneration Age-related macular degeneration (ARMD) is a degenerative condition of the macula (the central retina). It is the most common cause of vision loss in Americans age 50 and older, particularly in blue-eyed, post-menopausal females. Its prevalence increases with age. AMD is caused by arterial damage, which decreases blood flow into the capillaries that nourish the retina and macula and deprives the sensitive retinal tissue of oxygen and nutrients it needs to function and thrive. As a result the central vision deteriorates. The macula is located at the center of the retina. The retina sends light from the eye to the brain, and the macula allows you to see fine detail. Macular degeneration varies widely in severity. In the worst cases, ARMD causes a complete loss of central vision, making reading or driving impossible. For others, it may cause only slight distortion. Fortunately, macular degeneration does not cause total blindness since it does not affect the peripheral vision. Macular degeneration is classified as either wet (neovascular) or dry (non-neovascular). About 10% of people who suffer from macular degeneration have wet AMD. This type occurs when new vessels form to improve the blood supply to oxygen-deprived retinal tissue. However, the new vessels are very delicate and break easily, causing bleeding and damage to surrounding tissue. People with wet macular degeneration develop new blood vessels under the retina. This causes hemorrhage, swelling, and scar tissue. The more common form of AMD, dry macular degeneration, results in less severe, more gradual loss of vision. Macular degeneration may be caused by a variety of factors. Genetics, age, nutrition, smoking and sunlight exposure all play a role. Several peer-reviewed studies have shown a strong link between nutrition and the development of macular degeneration. It has been scientifically demonstrated that people with diets high in fruits and vegetables (especially dark green leafy vegetables and berries) have a lower incidence of macular degeneration. The almost seven year Age Related Eye Disease (ARED) study conducted by The National Eye Institute demonstrated a 25% decrease in the progression of diagnosed macular degeneration in those people who supplemented their diets with specific minerals and antioxidants.
|